Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioRestorative Therapies (BRTX) Invested Capital (2016 - 2025)

Historic Invested Capital for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to $4.2 million.

  • BioRestorative Therapies' Invested Capital fell 6895.1% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year decrease of 6895.1%. This contributed to the annual value of $11.1 million for FY2024, which is 1243.95% down from last year.
  • Per BioRestorative Therapies' latest filing, its Invested Capital stood at $4.2 million for Q3 2025, which was down 6895.1% from $7.4 million recorded in Q2 2025.
  • BioRestorative Therapies' 5-year Invested Capital high stood at $21.7 million for Q4 2021, and its period low was -$4.8 million during Q3 2021.
  • Its 5-year average for Invested Capital is $11.1 million, with a median of $12.8 million in 2023.
  • Per our database at Business Quant, BioRestorative Therapies' Invested Capital soared by 172644.0% in 2021 and then plummeted by 6895.1% in 2025.
  • Quarter analysis of 5 years shows BioRestorative Therapies' Invested Capital stood at $21.7 million in 2021, then decreased by 26.89% to $15.8 million in 2022, then fell by 20.27% to $12.6 million in 2023, then decreased by 12.44% to $11.1 million in 2024, then plummeted by 62.22% to $4.2 million in 2025.
  • Its Invested Capital was $4.2 million in Q3 2025, compared to $7.4 million in Q2 2025 and $9.3 million in Q1 2025.